Peptide therapy for fat loss is a research area that examines the use of peptides (short chains of amino acids) and peptide-like compounds to help the body manage weight. Peptides act like tiny “messengers” that help the body’s systems communicate. Researchers are studying whether certain peptides can affect hunger, how fast the body burns energy, how fat is stored, body composition (fat vs. muscle), and recovery after exercise or injury. There are five main categories of peptides, based on their function.
1) Peptides that target fat tissue and fat metabolism
Some compounds aim to act directly on fat cells or fat tissue. For example, 5-Amino-1MQ is being studied for blocking an enzyme in fat cells (NNMT) that may be linked to how fat cells store energy. Adipotide is designed to target the blood vessels that feed white fat tissue. Disrupting that blood supply may cause fat tissue to shrink. AOD-9604 is a small piece of human growth hormone made in a lab and studied for increasing fat breakdown and reducing new fat formation, with fewer broad effects than full growth hormone.
2) Peptides that reduce appetite through gut–brain signals
A major approach to weight loss is reducing hunger and helping people feel full sooner. Several well-known drugs work this way. Cagrilintide (an amylin-like compound) may increase fullness and slow stomach emptying. Semaglutide (a GLP-1 drug) helps regulate blood sugar and strongly reduces appetite for many people. Tirzepatide acts on two hormone pathways (GIP and GLP-1), which can improve blood sugar control and reduce calorie intake. Retatrutide is a next-generation “triple agonist” (GIP, GLP-1, and glucagon receptors) that may combine appetite reduction with higher energy burning. Tesofensine is not a peptide, but it may reduce appetite by changing brain chemicals involved in hunger.
3) Growth hormone (GH) / IGF-1 related peptides and body composition
Some peptides aim to increase the body’s natural growth hormone signalling, which may influence muscle, fat distribution, and recovery. CJC-1295 and ipamorelin are studied for boosting natural GH release. Tesamorelin is a GHRH drug used for reducing deep belly fat (visceral fat) in people with HIV-associated lipodystrophy and is also being studied for related metabolic issues. Follistatin is researched for blocking myostatin, a signal that normally limits muscle growth, so its effects on fat are often indirect through increased muscle.
4) Mitochondrial and cellular-energy modulators
Other compounds focus on how cells produce energy. MOTS-C is a mitochondrial-derived peptide studied for improving insulin sensitivity and metabolic stress responses. SLU-PP-332 (not a peptide) is described as an “exercise mimetic” in research. NAD+ therapies aim to support cellular energy and repair systems. SS-31 (elamipretide) targets mitochondria mainly for disease and fatigue-related conditions, with any secondary weight impacts.
5) Supportive peptides
Finally, some peptides (such as those for tissue healing, gut support, sleep, mood, or hormonal balance) are not direct fat-loss agents but may help people stay active, recover better, and maintain healthier habits.
